Literature DB >> 24092230

Diagnostic accuracy of 18F choline PET/CT using time-of-flight reconstruction algorithm in prostate cancer patients with biochemical recurrence.

Daniel Hausmann1, Leonardo K Bittencourt, Ulrike I Attenberger, Metin Sertdemir, Anja Weidner, Karen A Büsing, Joachim Brade, Frederik Wenz, Stefan O Schoenberg, Dietmar J Dinter.   

Abstract

PURPOSE: Image quality (IQ) of PET in voluminous body regions can be limited, which impairs the assessment of small metastatic lesions. Time-of-flight (TOF) reconstruction algorithm may deliver an increase of spatial resolution. The purpose of this study was to evaluate the impact of TOF on IQ, lesion detection rate, lesion volume (V) and SUVmax in F choline PET/CT of prostate cancer patients with biochemical recurrence compared to standard PET/CT reconstruction (standard). PATIENTS AND MATERIALS: During a period of 9 months, 32 patients with prostate cancer (mean [SD] age, 71 [7.8] years) and biochemical recurrence were included in this prospective institutional review board-approved study. Each patient underwent a state-of-the-art 3-dimensional F choline PET/CT. A total of 76 lesions were assessed by 2 board-certified nuclear medicine physicians and a third-year resident. Lesion volume and SUVmax of local recurrence, lymph nodes, and organ metastases were compared between TOF and standard. Image quality and lesion demarcation were rated according to a 5-point Likert-type scale. Interobserver agreement was assessed.
RESULTS: Eight additional lesions were detected using TOF (SUVmax, 3.64 [0.95]; V, 0.58 cm [0.50]). Image quality was reduced (IQ standard, 1.28; TOF, 1.77; P < 0.01) in calculated TOF images, although quality of lesion demarcation was improved (lesion demarcation: standard, 1.66; TOF, 1.26; P < 0.01). SUVmax was significantly increased in TOF images (SUVmax standard, 6.9 [4.1]; TOF, 8.1 [4.1]; P < 0.01), whereas V did not show significant differences (V standard, 5.3 [10.4] cm; TOF, 5.4 [10.3] cm; P = 0.41). Interobserver agreement was good for combined ratings (1 + 2 and 3 + 4).
CONCLUSIONS: Application of TOF seems to be of additional value to detect small metastatic lesions in patients with prostate cancer and biochemical recurrence, which may have further clinical implications for secondary treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24092230     DOI: 10.1097/RLU.0b013e3182a23d37

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  10 in total

1.  Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature.

Authors:  Chung Yao Yu; Bhushan Desai; Lingyun Ji; Susan Groshen; Hossein Jadvar
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-09-06

2.  Quantitative and Visual Assessments toward Potential Sub-mSv or Ultrafast FDG PET Using High-Sensitivity TOF PET in PET/MRI.

Authors:  Spencer C Behr; Emma Bahroos; Randall A Hawkins; Lorenzo Nardo; Vahid Ravanfar; Emily V Capbarat; Youngho Seo
Journal:  Mol Imaging Biol       Date:  2018-06       Impact factor: 3.488

Review 3.  Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy.

Authors:  Valeria Panebianco; Flavio Barchetti; Daniela Musio; Francesca De Felice; Camilla Proietti; Elena Lucia Indino; Valentina Megna; Orazio Schillaci; Carlo Catalano; Vincenzo Tombolini
Journal:  Biomed Res Int       Date:  2014-03-13       Impact factor: 3.411

Review 4.  New acquisition protocol of 18F-choline PET/CT in prostate cancer patients: review of the literature about methodology and proposal of standardization.

Authors:  Sotirios Chondrogiannis; Maria Cristina Marzola; Gaia Grassetto; Anna Margherita Maffione; Lucia Rampin; Emma Veronese; Arianna Massaro; Domenico Rubello
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

5.  Intra-individual comparison of PET/CT with different body weight-adapted FDG dosage regimens.

Authors:  Jan H Geismar; Paul Stolzmann; Bert-Ram Sah; Irene A Burger; Burkhardt Seifert; Gaspar Delso; Gustav K von Schulthess; Patrick Veit-Haibach; Lars Husmann
Journal:  Acta Radiol Open       Date:  2015-01-29

6.  Effect of Time-of-Flight and Regularized Reconstructions on Quantitative Measurements and Qualitative Assessments in Newly Diagnosed Prostate Cancer With 18F-Fluorocholine Dual Time Point PET/MRI.

Authors:  Spencer C Behr; Brett J Mollard; Jaewon Yang; Robert R Flavell; Randall A Hawkins; Youngho Seo
Journal:  Mol Imaging       Date:  2017 Jan-Dec       Impact factor: 4.488

7.  Medical Image Fusion Based on Feature Extraction and Sparse Representation.

Authors:  Yin Fei; Gao Wei; Song Zongxi
Journal:  Int J Biomed Imaging       Date:  2017-02-21

8.  Impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous 18F-choline PET/MRI for prostate cancer.

Authors:  Urs J Muehlematter; Hannes W Nagel; Anton Becker; Julian Mueller; Kerstin N Vokinger; Felipe de Galiza Barbosa; Edwin E G T Ter Voert; Patrick Veit-Haibach; Irene A Burger
Journal:  EJNMMI Res       Date:  2018-05-31       Impact factor: 3.138

Review 9.  Current opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.

Authors:  Gigin Lin; Yuen-Li Chung
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

10.  New prospects for PET in prostate cancer imaging: a physicist's viewpoint.

Authors:  Maurizio Conti
Journal:  EJNMMI Phys       Date:  2014-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.